PMS31 Cost-Effectiveness of Abatacept for the Treatment of Rheumatoid Arthritis (RA) After the Failure of a First TNF inhibitor in the United Kingdom

Nov 1, 2011, 00:00 AM
10.1016/j.jval.2011.08.417
https://www.valueinhealthjournal.com/article/S1098-3015(11)01979-6/fulltext
Section Title : Muscular-Skeletal Disorders
Section Order : 388
First Page : A307
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01979-6&doi=10.1016/j.jval.2011.08.417
HEOR Topics :
Tags :
Regions :